HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Dove invites users to create next ad

This article was originally published in The Rose Sheet

Executive Summary

For second year running, Unilever is challenging women to create a 30-second TV commercial that expresses how showering "in everyday luxury" with Dove Cream Oil Body Wash makes them feel. After contest closes Jan. 9, 2008, firm will enlist help of online voters to narrow down entries to two Grand Prize Winners, one of which may be revealed during a commercial break in the February 24 Oscars presentation. Dove Cream Oil Body Wash users can access online tools, artwork and photos provided by the company to design their ad or upload their own video file. Dove Cream Oil Body Wash launched in February 2007 (1"The Rose Sheet" Jan. 1, 2007, In Brief)

You may also be interested in...



Dove body wash ad campaign

Unilever is turning to women everywhere in a search for ads to support the launch of its new Dove Cream Oil Body Wash. Contestants can submit their 30-second TV spots online at the AOL-hosted site 1www.DoveCreamOil.com. Entries will be accepted through Jan. 15, with the winning ad premiering in a commercial break during the Feb. 25 Academy Awards, Unilever says. The firm launched its "Campaign for Real Beauty" in 2004 (2"The Rose Sheet" Nov. 1, 2004, p. 5). Designed to challenge public notions of beauty, the campaign grew in 2005 to promote Dove Firming products (3"The Rose Sheet" May 23, 2005, p. 4). Cream Oil Body Wash is slated to hit store shelves in February...

New EU Filings

Obecabtagene autoleucel, Autolus Therapeutics’s investigational treatment for relapsed or refractory B cell precursor acute lymphoblastic leukemia, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.

P&G Restores Volume Growth In Beauty, Grooming After Pricing Run

Procter & Gamble reports strong consumer spending in the US and Europe after a 3% increase in product pricing over the past year. Dragging on fiscal third-quarter results, sales of SK-II in China fell 30% for the January-March period, while lower incidence of cough and cold impacted Health Care performance.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS015134

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel